Michael Parker, MD, PhD, Clinical Genetics, Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust

Michael Parker, MD, PhD - Clinical Genetics

Dr. Parker was appointed as a Consultant Clinical Geneticist at Sheffield Children’s Hospitals Trust in January 2003. He is one of seven Consultants in the Sheffield Clinical Genetics Service, which covers a population of approximately 1.8 million in South Yorkshire, North Derbyshire and the East Riding. This is a largely out-patient specialty, with some ward referrals. Although now based at the Northern General Hospital, most of his clinical work is done in peripheral hospitals. His background is in Paediatrics and his sub-specialty interest is Paediatric Genetics, particularly Dysmorphology, Learning Difficulties, Deafness and Looked After Children. He regularly presents cases at local, regional, national and international Dysmorphology meetings. He is also the departmental lead for the Joint Cleft Lip & Palate and Eye Genetic Clinics. He helps to facilitate the following MDT’s: Paediatric Neurology & Genetics, Paediatric Neurodisability and Genetics, and Ophthalmology & Genetics. He represents the department at a Trust Agile Working group initiative. Dr. Parker attended patient/family conferences organised by the Unique Patient Support Group, giving talks and clinics, in the capacity of Expert Adviser. He has also fundraised, most recently running the London Marathon, for this group. He is currently the National Convenor between the Clinical Genetics Society (CGS) and Royal College of Paediatrics & Child Health (RCPCH). The three main roles of this post are to: 1) organise a Genetics sub-group session at the national RCPCH conference; 2) to facilitate CGS contributions to relevant consultation documents produced by RCPCH; and 3) represent CGS at bi-annual Speciality Group meeting at RCPCH. He is also co-opted to the CGS Council in this role He has recently written a Congenital Malformations module for the RCPCH Paediatric Care Online UK programme currently under development. He is a member of the British Society for Genetic Medicine’s Ethics and Policy Committee and have attended an inaugural joint meeting of this body and the GenEthics Club in relation to the 100,000 Genomes Project Practical Ethics GeCIP,considering the ethical aspects of this new, national genomics initiative.